A Milestone Moment: FDA Approves Addyi® for Hypoactive Sexual Desire Disorder in Postmenopausal Women
December 17, 2025
Free CME credits
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
Brand Name :
N/A
Synonyms :
Ethenzamide, etenzamida, etenzamide, ethbenzamide, ethenzamidum
Class :
Analgesic/antipyretics
Brand Name :
N/A
Synonyms :
Ethenzamide, etenzamida, etenzamide, ethbenzamide, ethenzamidum
Class :
Analgesic/antipyretics
Data not available
Refer to adult dosing
the rate of excretion of abacavir may be reduced
the risk of hemorrhage and bleeding may be increased
the risk of adverse effects may be increased
the protein binding efficacy of acetohexamide may be reduced
the risk of nephrotoxicity may be increased
the risk of adverse effects may be increased
the rate of excretion of almasilate may be reduced
the risk of adverse effects may be increased
amitriptylinoxide(Phase 4 Clinical Trials)
the risk of gastrointestinal bleeding can be increased
the risk of hypertension may be increased
the risk of hypertension may be increased
the risk of adverse effects may be increased
the risk of nephrotoxicity may be increased
the risk of hypertension, kidney failure, and hypokalemia may be increased
Actions and spectrum:
Ethenzamide inhibits the synthesis of prostaglandins by blocking the activity of cyclooxygenase
Frequency not defined
Headache
Hypotension
Dizziness
Drowsiness
Black Box Warning
Do not operate heavy vehicles or operate machinery
Contraindication/Caution:
Contraindication:
Hypersensitivity
Pregnancy consideration:
USFDA pregnancy category: Not assigned
Lactation:
It is safe to use ethenzamide in lactating mothers
Pregnancy category:
Category A: Studies that were well-controlled and met expectations revealed no risk to the fetus in either the first or second trimester.
Category B: There was a lack of studies on pregnant women and no evidence of risk to the fetus in animal experiments.
Category C: there was evidence of risk of adverse effects in animal reproduction studies, and no adequate evidence in human studies must take care of potential risks in pregnant women.
Category D: adequate data with sufficient evidence of human fetal risk from various platforms, but despite the potential risk, and used only in emergency cases for potential benefits.
Category X: Drugs listed in this category outweigh the risks over benefits. Hence, these categories of drugs need to be avoided by pregnant women.
Category N: There is no data available for the drug under this category
Pharmacology:
Ethenzamide is an analgesic antipyretic drug
Pharmacodynamics:
It exerts its action by inhibiting the activity of the enzyme cyclooxygenase
Pharmacokinetics:
Limited data available
Administration:
To be administered orally after taking food
Patient information leaflet
Generic Name: ethenzamide
Why do we use ethenzamide?
Ethenzamide is an analgesic, antipyretic, and inflammatory drug. It is used to treat inflammation due to the common cold. It is also used to relieve pain.
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
On course completion, you will receive a full-sized presentation quality digital certificate.
A dynamic medical simulation platform designed to train healthcare professionals and students to effectively run code situations through an immersive hands-on experience in a live, interactive 3D environment.
When you have your licenses, certificates and CMEs in one place, it's easier to track your career growth. You can easily share these with hospitals as well, using your medtigo app.
